JPArcana Consulting

JPArcana.com

JP Arcana Consulting is a SINGAPORE based boutique-consulting firm built on a network of consultants with a wealth of experience in the execution of integrated marketing solutions. According to your requirements, JP Arcana Consulting offer you a tailor-made service package to enable your smooth and efficient entry onto the market in ASEAN countries.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact, Diagnostics

AVID BIOSERVICES UNVEILS COMPLETED MAMMALIAN CELL FACILITIES EXPANSION PROVIDING SIGNIFICANTLY INCREASED CAPACITY FOR EXISTING AND FUTURE CUSTOMERS

Globenewswire | April 10, 2023

news image

Avid Bioservices, Inc. a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced the completion of two expansions within the company’s mammalian cell facilities. The company expects that the first customer for the newly expanded CGMP mammalian cell suites will begin manufacture this month. To celebrate the launch of...

Read More

Industrial Impact

VERSANT VENTURES COLLABORATES WITH ABCELLERA TO ACCELERATE DRUG DEVELOPMENT FOR ITS PORTFOLIO OF BIOTECH COMPANIES

AbCellera and Versant Ventures | July 28, 2022

news image

AbCellera and Versant Ventures announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm’s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies will have rights to develop and commercialize the resulting therapeutic antibodies. AbCellera will receive resear...

Read More

Industrial Impact

ALLOY THERAPEUTICS AND NORMUNITY SIGN MULTI-PROGRAM ANTIBODY DISCOVERY COLLABORATION IN IMMUNO-ONCOLOGY

Alloy Therapeutics | November 18, 2022

news image

Alloy Therapeutics, a biotechnology ecosystem company, announced an antibody discovery collaboration spanning multiple precision immuno-oncology programs for Normunity, a biotech company that recently announced its $65 million Series A financing. The collaboration will support the advancement of Normunity’s immune normalizers, antibody therapies designed to target novel mechanisms that free the body’s normal immunity to fight cancer, which are conceived through a unique biotech-acade...

Read More

Cell and Gene Therapy

SYSMEX AND THINKCYTE HAVE ENTERED INTO AN AGREEMENT FOR JOINT DEVELOPMENT AND CAPITAL ALLIANCE

Sysmex Corporation | May 17, 2021

news image

Sysmex Corporation and ThinkCyte, Inc. announced today the signing of joint development and investment agreements for the commercialization of an AI-based cell analysis technology in May 2021. The development of novel testing and diagnostic technologies of high clinical utility is being pursued to improve the precision of diagnoses and maximize treatment as healthcare becomes more accurate and personalized at an increased pace - in combination with the advancement of technology. M...

Read More
news image

Industrial Impact, Diagnostics

AVID BIOSERVICES UNVEILS COMPLETED MAMMALIAN CELL FACILITIES EXPANSION PROVIDING SIGNIFICANTLY INCREASED CAPACITY FOR EXISTING AND FUTURE CUSTOMERS

Globenewswire | April 10, 2023

Avid Bioservices, Inc. a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced the completion of two expansions within the company’s mammalian cell facilities. The company expects that the first customer for the newly expanded CGMP mammalian cell suites will begin manufacture this month. To celebrate the launch of...

Read More
news image

Industrial Impact

VERSANT VENTURES COLLABORATES WITH ABCELLERA TO ACCELERATE DRUG DEVELOPMENT FOR ITS PORTFOLIO OF BIOTECH COMPANIES

AbCellera and Versant Ventures | July 28, 2022

AbCellera and Versant Ventures announced a multi-year collaboration to discover therapeutic antibodies for multiple targets selected by Versant’s portfolio of biologics-focused biotechs. Versant and AbCellera already have enabled three of the firm’s stealth-stage companies under previous partnerships. Under the terms of the deal, Versant portfolio companies will have rights to develop and commercialize the resulting therapeutic antibodies. AbCellera will receive resear...

Read More
news image

Industrial Impact

ALLOY THERAPEUTICS AND NORMUNITY SIGN MULTI-PROGRAM ANTIBODY DISCOVERY COLLABORATION IN IMMUNO-ONCOLOGY

Alloy Therapeutics | November 18, 2022

Alloy Therapeutics, a biotechnology ecosystem company, announced an antibody discovery collaboration spanning multiple precision immuno-oncology programs for Normunity, a biotech company that recently announced its $65 million Series A financing. The collaboration will support the advancement of Normunity’s immune normalizers, antibody therapies designed to target novel mechanisms that free the body’s normal immunity to fight cancer, which are conceived through a unique biotech-acade...

Read More
news image

Cell and Gene Therapy

SYSMEX AND THINKCYTE HAVE ENTERED INTO AN AGREEMENT FOR JOINT DEVELOPMENT AND CAPITAL ALLIANCE

Sysmex Corporation | May 17, 2021

Sysmex Corporation and ThinkCyte, Inc. announced today the signing of joint development and investment agreements for the commercialization of an AI-based cell analysis technology in May 2021. The development of novel testing and diagnostic technologies of high clinical utility is being pursued to improve the precision of diagnoses and maximize treatment as healthcare becomes more accurate and personalized at an increased pace - in combination with the advancement of technology. M...

Read More

Resources

resource image

Cell and Gene Therapy

VIA Thaw™ automated dry thawer

Video

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us